We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.08B
AUM Growth
+$20.7M
Cap. Flow
-$60.6M
Cap. Flow %
-5.62%
Top 10 Hldgs %
20.95%
Holding
208
New
36
Increased
50
Reduced
44
Closed
33

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$22.8M
2
LEGN icon
Legend Biotech
LEGN
+$18.8M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$16.1M
4
SWTX
SpringWorks Therapeutics
SWTX
+$16M
5
UTHR icon
United Therapeutics
UTHR
+$15.2M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20M
2
HQY icon
HealthEquity
HQY
+$18.6M
3
ESI icon
Element Solutions
ESI
+$17.4M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.2M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 44.2%
2 Technology 15.96%
3 Industrials 9.72%
4 Energy 6.59%
5 Consumer Staples 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
26
DELISTED
Apellis Pharmaceuticals
APLS
$13.3M 1.23%
194,513
+69,018
+55% +$4.08M
CACI icon
27
CACI
CACI
$14.2B
$12.9M 1.2%
49,535
+7,585
+18% +$2.14M
CELH icon
28
Celsius Holdings
CELH
$7.03B
$12.9M 1.2%
+426,903
New +$13.4M
INSP icon
29
Inspire Medical Systems
INSP
$1.74B
$12.1M 1.12%
68,171
+4,703
+7% +$945K
CALY
30
Callaway Golf Company
CALY
$3.14B
$12.1M 1.12%
626,033
+430,034
+219% +$9.5M
VEEV icon
31
Veeva Systems
VEEV
$37.4B
$12M 1.11%
72,814
+16,719
+30% +$3.34M
STAA icon
32
STAAR Surgical
STAA
$1.21B
$11.7M 1.09%
+166,316
New +$14.2M
CVX icon
33
Chevron
CVX
$366B
$11.7M 1.08%
81,350
-11,350
-12% -$1.73M
TMDX icon
34
Transmedics
TMDX
$2.91B
$11.6M 1.07%
+277,625
New +$12.1M
TWST icon
35
Twist Bioscience
TWST
$7.25B
$11.3M 1.05%
320,168
+48,142
+18% +$2.04M
KDNY
36
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$11.2M 1.03%
567,415
+17,561
+3% +$352K
VRRM icon
37
Verra Mobility
VRRM
$744M
$11M 1.02%
715,520
+63,218
+10% +$1.03M
THS
38
DELISTED
Treehouse Foods
THS
$10.9M 1.01%
256,702
-159,735
-38% -$7.16M
AAPL icon
39
Apple
AAPL
$4.57T
$10.8M 1%
78,206
+12,203
+18% +$1.92M
PODD icon
40
Insulet
PODD
$9.79B
$10.7M 1%
46,818
-44,785
-49% -$11.2M
LSCC icon
41
Lattice Semiconductor
LSCC
$18.5B
$10.7M 0.99%
217,010
-72,792
-25% -$4.03M
DKS icon
42
Dick's Sporting Goods
DKS
$18.7B
$10.3M 0.95%
97,979
+27,995
+40% +$2.85M
MSFT icon
43
Microsoft
MSFT
$3.71T
$10.1M 0.94%
43,567
-9,079
-17% -$2.4M
RRX icon
44
Regal Rexnord
RRX
$11.9B
$9.68M 0.9%
68,992
+2,363
+4% +$317K
ALNY icon
45
Alnylam Pharmaceuticals
ALNY
$29.3B
$9.67M 0.9%
48,302
+1,222
+3% +$233K
RLMD icon
46
Relmada Therapeutics
RLMD
$527M
$9.01M 0.84%
+243,385
New +$6.74M
ESTC icon
47
Elastic
ESTC
$7.81B
$8.53M 0.79%
118,833
+20,169
+20% +$1.6M
IRDM icon
48
Iridium Communications
IRDM
$5.29B
$8.04M 0.75%
+181,147
New +$7.85M
FIVN icon
49
FIVE9
FIVN
$2.54B
$8.02M 0.74%
106,957
+36,008
+51% +$3.5M
PIII icon
50
P3 Health Partners
PIII
$38.5M
$7.9M 0.73%
34,193
– –
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Nicholas Investment Partners held 208 positions worth $1.08B, up 2% from $1.06B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $60.6M in Q3 2022, closing 33 positions and reducing 44 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Cytokinetics worth $22.9M.

  • Nicholas Investment Partners's largest Q3 2022 buy was Cytokinetics: 472,839 shares worth $22.9M.
  • Nicholas Investment Partners added most to Callaway Golf Company in Q3 2022, an estimated $9.5M increase.
  • Nicholas Investment Partners's biggest Q3 2022 reduction was IVERIC bio, Inc. Common Stock, cutting an estimated $14.2M.
  • Nicholas Investment Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.08B portfolio in Q3 2022.
  • Nicholas Investment Partners opened 36 new positions and closed 33 in Q3 2022.
  • Nicholas Investment Partners's portfolio value rose 2% quarter-over-quarter to $1.08B.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.